Genmab Confident It Has Edge Over Roche In Bispecific Battle

Epcoritamab Tipped To Lead Rival CD20xCD3 Drugs

 
• By Andrew McConaghie
  
Genmab Office Copenhagen - close up
Genmab only recently launched its commercial division with Tivdak, but is now preparing for a possible 2023 launch of epcoritamab. • Source: Genmab
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip